Ardestani Shidrokh, Deskins Desirae L, Young Pampee P
Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, 1161 21st Avenue South, C2217A MCN, Nashville, TN 37232, USA.
J Mol Signal. 2013 Nov 1;8(1):12. doi: 10.1186/1750-2187-8-12.
Programmed necrosis is a form of caspase-independent cell death whose molecular regulation is poorly understood. While tumor necrosis factor-alpha (TNF-α) has been identified as an activator of programmed necrosis, the specific context under which this can happen is unclear. Recently we reported that TNF-α can be expressed by human tumor cells as both a membrane tethered (mTNF-α) and a soluble (sTNF-α) form. Whereas low level, tumor-derived sTNF-α acts as a tumor promoter, tumor cell expression of mTNF-α significantly delays tumor growth in mice, in large part by induction of programmed necrosis of tumor associated myeloid cells. In this study we sought to determine the molecular mechanism involved in mTNF-α oxidative stress-induced cell death by evaluating the known pathways involved in TNF receptor-induced programmed necrosis.
The source of Reactive Oxygen Species (ROS) in mTNF-α treated cells was determined by coculturing RAW 264.7 monocytic and L929 fibroblasts cells with fixed B16F10 control or mTNF-α expressing-melanoma cells in the presence of inhibitors of NADPH and mitochondria ROS. To identify the down-stream effector of TNF-a receptors (TNFR), level of phospho-RIP-1 and ceramide activity were evaluated.To determine whether mTNF-mediated cell death was dependent on a specific TNFR, cell death was measured in primary CD11b myeloid cells isolated from wild-type or TNFR-1, TNFR-2, TNFR-1 and TNFR-2 double knockout mice, cocultured with various TNF-α isoform.
Tumor derived-mTNF-α increased ROS-mediated cytotoxicity, independent of caspase-3 activity. Although TNFR on target cells were required for this effect, we observed that mTNF-induced cell death could be mediated through both TNFR-1 and the death domain-lacking TNFR-2. ROS generation and cytotoxicity were inhibited by a mitochondrial respiratory chain inhibitor but not by an inhibitor of NADPH oxidase. mTNF-α mediated cytotoxicity was independent of RIP-1, a serine/threonine kinase that serves as a main adaptor protein of sTNF-α induced programmed necrosis. Instead, mTNF-α-induced ROS and cell death was prohibited by the ceramide-activated protein kinase (CAPK) inhibitor.
These findings demonstrate that the mTNF-α isoform is an effective inducer of programmed necrosis through a caspase independent, ceramide-related pathway. Interestingly, unlike sTNFα, mTNF-induced programmed necrosis is not dependent on the presence of TNFR1.
程序性坏死是一种不依赖半胱天冬酶的细胞死亡形式,其分子调控机制尚不清楚。虽然肿瘤坏死因子-α(TNF-α)已被确定为程序性坏死的激活剂,但这种情况发生的具体背景尚不清楚。最近我们报道,TNF-α可由人类肿瘤细胞以膜结合形式(mTNF-α)和可溶性形式(sTNF-α)表达。低水平的肿瘤源性sTNF-α作为肿瘤促进剂,而肿瘤细胞表达的mTNF-α则显著延迟小鼠肿瘤生长,这在很大程度上是通过诱导肿瘤相关髓样细胞的程序性坏死实现的。在本研究中,我们试图通过评估参与TNF受体诱导的程序性坏死的已知途径,来确定mTNF-α氧化应激诱导细胞死亡所涉及的分子机制。
通过在存在NADPH和线粒体ROS抑制剂的情况下,将RAW 264.7单核细胞和L929成纤维细胞与固定的B16F10对照或表达mTNF-α的黑色素瘤细胞共培养,来确定mTNF-α处理细胞中活性氧(ROS)的来源。为了鉴定TNF-α受体(TNFR)的下游效应器评估磷酸化RIP-1水平和神经酰胺活性。为了确定mTNF介导的细胞死亡是否依赖于特定的TNFR,在从野生型或TNFR-1、TNFR-2、TNFR-1和TNFR-2双敲除小鼠分离的原代CD11b髓样细胞中测量细胞死亡,这些细胞与各种TNF-α同工型共培养。
肿瘤源性mTNF-α增加了ROS介导的细胞毒性,与半胱天冬酶-3活性无关。虽然这种效应需要靶细胞上的TNFR,但我们观察到mTNF诱导的细胞死亡可通过TNFR-1和缺乏死亡结构域的TNFR-2介导。线粒体呼吸链抑制剂可抑制ROS的产生和细胞毒性,但NADPH氧化酶抑制剂则不能。mTNF-α介导的细胞毒性与RIP-1无关,RIP-1是一种丝氨酸/苏氨酸激酶,是sTNF-α诱导的程序性坏死的主要衔接蛋白。相反神经酰胺激活蛋白激酶(CAPK)抑制剂可抑制mTNF-α诱导的ROS和细胞死亡。
这些发现表明,mTNF-α同工型是通过一条不依赖半胱天冬酶、与神经酰胺相关的途径诱导程序性坏死的有效诱导剂。有趣的是,与sTNFα不同,mTNF诱导的程序性坏死不依赖于TNFR1的存在。